A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Hospital, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology, Other |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 1/20/2019 |
| Start Date: | March 2019 |
| End Date: | October 2023 |
| Contact: | Annell Ovalles, BA |
| Email: | ano2015@med.cornell.edu |
| Phone: | 212-821-0783 |
A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to Military Sexual Trauma
The purpose of this study is to compare two kinds of therapy for Posttraumatic Stress
Disorder (PTSD): exposure therapy (ET) and Interpersonal Psychotherapy (IPT). The results of
this study will allow us to see if IPT and ET are equally effective in treating PTSD due to
Military Sexual Trauma, with the long-term goal of making PTSD treatment effective for as
many people as possible.
Disorder (PTSD): exposure therapy (ET) and Interpersonal Psychotherapy (IPT). The results of
this study will allow us to see if IPT and ET are equally effective in treating PTSD due to
Military Sexual Trauma, with the long-term goal of making PTSD treatment effective for as
many people as possible.
Inclusion Criteria:
- English-speaking
- Military Sexual Trauma (MST) survivors, with MST defined as actual or threatened
sexual violence, from Vietnam era to current Operation Iraqi Freedom/Operation
Enduring Freedom/Operation New Dawn
- Diagnosed with PTSD consequent to MST, with a minimum CAPS score > 40
- Medically stable at time of study enrollment (for persons with chronic injuries and
that any disability present does not prevent attendance of weekly outpatient therapy
sessions)
- Ability to provide informed consent and function at an intellectual level sufficient
to allow accurate completion of all assessment instruments
- Stable on psychotropic medication for the prior 60 days
Exclusion Criteria:
- Lifetime or current diagnosis of schizophrenia or other psychotic disorder, bipolar
disorder
- Participation in a clinical trial or concurrent evidence-based treatment for
MST-related psychiatric conditions or PTSD during the previous 3 months
- Current evidence of significant unstable medical illness or organic brain impairment
such that the patient could not attend sessions regularly or complete assessments
- Patients who in the investigator's judgment pose a current homicidal or suicidal risk
- Current or history of substance dependence in the past 90 days.
We found this trial at
1
site
Click here to add this to my saved trials
